1-20 of 68
Jakob Passweg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of CD19-Directed CAR T Cell Therapy in Patients with Primary or Secondary CNS Lymphoma - an Analysis of the EBMT Lymphoma WP and the Gocart Coalition

Anna Ossami Saidy, Stephan Fuhrmann, Christophe Peczynski, Ariane Boumendil, Eva Michel, Jacques-Emmanuel Galimard, Hervé Finel, Michael Daskalakis, Urban Novak, David Beauvais, Peter Vandenberghe, Nicolaus Kröger, Ron Ram, Jürgen Finke, Matthias Stelljes, Gerald G. Wulf, Wolfgang Andreas Bethge, Malte von Bonin, Gesine Bug, Andrea Kuhnl, Jakob Passweg, Sr., Friedrich Stoelzel, Bastian von Tresckow, Anna Maria Sureda Balari, Peter Dreger, Norbert Schmitz, Bertram Glass
Journal: Blood
Blood (2023) 142 (Supplement 1): 1031.
https://doi.org/10.1182/blood-2023-174883
Published: 2023
Journal Articles

Impact of Post-Transplant Cyclophosphamide (PTCY)-Based Prophylaxis in Matched Sibling Donor Allo-HCT for Patients with Myelodysplastic Syndrome: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

Maria Queralt Salas, Dirk-Jan Eikema, Sr., Linda Koster, Johan Maertens, Jakob Passweg, Sr., Jürgen Finke, Annoek E.C. Broers, Yener Koc, Nicolaus Kröger, Zubeyde Nur Ozkurt, Maria Jesús Pascual, Uwe Platzbecker, Gwendolyn Van Gorkom, Thomas Schroeder, Jose Luiz Lopez Lorenzo, Massimo Martino, Simona Sica, Martin Kaufmann, Francesco Onida, Carmelo Gurnari, Christof Scheid, Joanna Drozd-Sokolowska, Kavita Raj, Marie Robin, Donal P McLornan
Journal: Blood
Blood (2023) 142 (Supplement 1): 4938.
https://doi.org/10.1182/blood-2023-174609
Published: 2023
Journal Articles

Prognostic Value of Measurable Residual Disease in High-Risk Myelodysplastic Syndromes with Intensive Chemotherapy Treatment: Analysis of HOVON-SAKK Studies

Lok Lam Ngai, Coen R. Veenstra, Patrycja Gradowska, Angèle Kelder, Willemijn Scholten, Alexander N. Snel, Jesse M. Tettero, Costa Bachas, Dimitri Breems, Thomas Fischer, Bjorn T. Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan Maertens, Markus G. Manz, Thomas Pabst, Jakob Passweg, Sr., Kimmo Porkka, Canan Alhan, Theresia M. Westers, Peter J. M. Valk, David C. de Leeuw, Bob Lowenberg, Gert Ossenkoppele, Jacqueline Cloos, Arjan A. van de Loosdrecht
Journal: Blood
Blood (2023) 142 (Supplement 1): 323.
https://doi.org/10.1182/blood-2023-184703
Published: 2023
Journal Articles

Alternative Donor Transplantation for Severe Aplastic Anemia: A Comparative Study of the Saawp EBMT

Juan Montoro, Dirk-Jan Eikema, Sr., Joe Tuffnell, Sr., Victoria Potter, Krzysztof Kalwak, Sr., Stijn Halkes, Sr., Aleksandr Kulagin, Sr., Matthew P. Collin, Sr., Robert Wynn, Sr., Stephen Robinson, Jr., Emma Nicholson, Sr., Henrik Sengeloev, Jennifer Clay, Sr., Khaled Halahleh, Sr., Elena Skorobogatova, Sr., Jakob Passweg, Sr., Stephan Mielke, Samppa Ryhanen, Sr., Ben Carpenter, Tobias Gedde-Dahl, Eleni Tholouli, Renato Fanin, Philippe Lewalle, Sr., Austin Kulasekararaj, Antonio M Risitano, Regis Peffault De Latour
Journal: Blood
Blood (2023) 142 (Supplement 1): 1047.
https://doi.org/10.1182/blood-2023-174724
Published: 2023
Journal Articles

Interindividual HLA Evolutionary Divergence in Single HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders: A Report on Behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT

Simona Pagliuca, Jarl Mooyaart, Nicolaus Kröger, Jürgen Finke, Victoria Potter, Peter Dreger, Inken Hilgendorf, Wolfgang Andreas Bethge, Regis Peffault De Latour, Alessandro Rambaldi, Henrik Sengeloev, Jakob Passweg, Tobias Gedde-Dahl, David Burns, Kim Orchard, Stephan Mielke, Matthias Edinger, Marco Andreani, Pietro Crivello, Pietro Merli, Jorinde D. Hoogenboom, Liesbeth C. de Wreede, Christian Chabannon, Jurgen Kuball, Carmelo Gurnari, Katharina Fleischhauer, Annalisa Ruggeri, Tobias Lenz
Journal: Blood
Blood (2023) 142 (Supplement 1): 895.
https://doi.org/10.1182/blood-2023-187622
Published: 2023
Journal Articles

The Laip-Based-Dfn Approach Is Superior in Terms of Useful MRD Results As Compared to the Laip Approach after Cycle II in Acute Myeloid Leukemia

Lok Lam Ngai, Diana Hanekamp, Angèle Kelder, Willemijn Scholten, Jannemieke Carbaat-Ham, Mona M.H.E Fayed, Alexander N. Snel, Costa Bachas, Jesse M. Tettero, Tim R. Mocking, Vincent H.J. Van Der Velden, Jennichjen Slomp, Willemijn Hobo, Dimitri Breems, Thomas Fischer, Bjorn T. Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Johan Maertens, Markus G. Manz, Thomas Pabst, Jakob Passweg, Sr., Kimmo Porkka, Peter J. M. Valk, Patrycja Gradowska, Bob Löwenberg, David C. de Leeuw, Arjan A. van de Loosdrecht, Gert Ossenkoppele, Jacqueline Cloos
Journal: Blood
Blood (2023) 142 (Supplement 1): 1572.
https://doi.org/10.1182/blood-2023-181709
Published: 2023
Journal Articles

A Multi-Center Retrospective Analysis of Outcomes Post Allogeneic Stem Cell Transplantation in AML Patients with TET2 Mutations: A Study on Behalf of the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Lin Li, Yishan Ye, Jacques-Emmanuel Galimard, Myriam Labopin, Depei Wu, Jia Chen, Nicolaus Kröger, Jakob Passweg, Sr., Urpu Salmenniemi, Maija Itäla-remes, Xavier Poiré, Matthias Eder, Johan Maertens, David Burns, Henrik Sengeloev, Gitte Olesen, Didier Blaise, Jürgen Finke, Alain Gadisseur, Ali Bazarbachi, Eolia Brissot, Arnon Nagler, Yi Luo, Jimin Shi, Fabio Ciceri, Mohamad Mohty, He Huang, Norbert Claude Gorin, Sr.
Journal: Blood
Blood (2023) 142 (Supplement 1): 4986.
https://doi.org/10.1182/blood-2023-185685
Published: 2023
Journal Articles

Measurable Residual Disease Guided Therapy in Intermediate-Risk AML Patients Compared to an Unguided Cohort Using Propensity Score Matching

Jesse M. Tettero, Lok Lam Ngai, Costa Bachas, Dimitri A. Breems, Thomas Fischer, Bjørn Tore Gjertsen, Patrycja Gradowska, Laimonas Griskevicius, Jeroen J.W.M. Janssen, Gunnar Juliusson, Johan A. Maertens, Markus G Manz, Thomas Pabst, Jakob Passweg, Kimmo Porkka, Peter JM Valk, Bob Lowenberg, Gert J. Ossenkoppele, Jacqueline Cloos
Journal: Blood
Blood (2022) 140 (Supplement 1): 2027–2029.
https://doi.org/10.1182/blood-2022-157009
Published: 2022
Journal Articles

Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients >60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study

Dietger Niederwieser, Dirk Hasenclever, Wolfgang E. Berdel, Bart J. Biemond, Haifa Kathrin Al-Ali, Yves Chalandon, Michel Van Gelder, Christian Junghanss, Goesta Gahrton, Mathias Haenel, Rüdiger Hehlmann, Thomas Heinicke, Andreas Hochhaus, Simona Iacobelli, Rien van Marwijk Kooy, Nicolaus Kröger, Jeroen J.W.M. Janssen, Madlen Jentzsch, Frank Breywisch, Mohamad Mohty, Stavroula Masouridi-Levrat, Gert Ossenkoppele, Jakob Passweg, Wolfram Pönisch, Johannes Schetelig, Christoph Schliemann, Sebastian Schwind, Matthias Stelljes, Peter JM Valk, Bob Lowenberg, Jan J. Cornelissen
Journal: Blood
Blood (2022) 140 (Supplement 1): 2126–2129.
https://doi.org/10.1182/blood-2022-157684
Published: 2022
Journal Articles

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Different Donor Types in Primary Refractory Acute Myeloid Leukemia: A Report from the ALWP of the EBMT

Kordelia Barbullushi, Myriam Labopin, Nicolaus Kröger, Jürgen Finke, Matthias Stelljes, Arnold Ganser, Wolfgang Bethge, Hermann Einsele, Johannes Schetelig, Renato Fanin, Pavel Jindra, Jochen Casper, Thomas Schroeder, Matthias Edinger, Jakob Passweg, Edouard Forcade, Johanna Tischer, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2022) 140 (Supplement 1): 10613–10615.
https://doi.org/10.1182/blood-2022-165472
Published: 2022
Journal Articles

Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation

Alexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl, Arnold Ganser, Matthias Stelljes, Charles Craddock, Eva Maria Wagner, Jurjen Versluis, Thomas Schroeder, Igor Wolfgang Blau, Gerald Wulf, Peter Dreger, Gitte Olesen, Henrik Sengeloev, Nicolaus Kröger, Victoria Potter, Edouard Forcade, Jakob Passweg, Régis Peffault de Latour, Johan Maertens, Keith Wilson, Jean-Henri Bourhis, Bipin Savani, Fabio Ciceri, Arnon Nagler, Mohamad Mohty
Journal: Blood
Blood (2022) 140 (Supplement 1): 2389–2391.
https://doi.org/10.1182/blood-2022-157890
Published: 2022
Journal Articles

Escape from Type II JAK2 Inhibition in MPN Depends on AXL/MAPK Activation and Is Targetable

Tamara Codilupi, Jakub Szybinski, Sime Brkic, Simona Stivala, Julie Yang, Nilabh Ghosh, Katarzyna Buczak, Jakob Passweg, Anne Angelillo-Scherrer, Stefan Dirnhofer, Ross L. Levine, Richard Koche, Sara C. Meyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 3850–3851.
https://doi.org/10.1182/blood-2022-159068
Published: 2022
Journal Articles

Severe Cytopenia after CD19 CAR T-Cell Therapy: A Retrospective Study from the EBMT Transplant Complications Working Party

Olaf Penack, Christophe Peczynski, Christian Koenecke, Emmanuelle Polge, Victoria Potter, Nathalie Fegueux, Michael Daskalakis, Nicolaus Kröger, Peter Dreger, Caroline Besley, Urs Schanz, Adrian Bloor, Arnold Ganser, Edouard Forcade, Lucía López Corral, Jakob Passweg, Urban Novak, Ivan Moiseev, Helene Schoemans, Grzegorz W. Basak, Christian Chabannon, Anna Sureda, Diana Averbuch, Bertram Glass, Rafael De La Camara, Zinaida Peric
Journal: Blood
Blood (2022) 140 (Supplement 1): 4664–4667.
https://doi.org/10.1182/blood-2022-168614
Published: 2022
Journal Articles

Outcomes of Allogeneic Haematopoietic Stem Cell Transplantation for Therapy-Related Myeloid Neoplasms Following Treatment for Myeloma

Sarah Lawless, Curly Morris, Dirk-Jan Eikema, Linda Kostner, Friedrich Stoelzel, Nicolaus Kröger, Uwe Platzbecker, Wolfgang Bethge, Peter Brossart, Renato Fanin, Jürgen Finke, Jurgen Kuball, Veronique Leblond, Emma Nicholson, Jakob Passweg, Daniele Avenoso, Jacques-Olivier Bay, Ali Bazarbachi, Dolores Caballero, Joanna Drozd-Sokolowska, Christof Scheid, Donal P. McLornan, Marie Robin, Ibrahim Yakoub-Agha
Journal: Blood
Blood (2022) 140 (Supplement 1): 4884–4885.
https://doi.org/10.1182/blood-2022-169326
Published: 2022
Journal Articles

Conditioning Regimen Intensity and Donor Choice Do Not Impact Outcomes of Patients (pts) with Acute Myeloid Leukemia (AML) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in First Complete Remission (CR1): An EBMT Analysis

Razan Mohty, Myriam Labopin, Jean Henri Bouhris, Ibrahim Yakoub-Agha, Urpu Salmenniemi, Anne Huynh, Eolia Brissot, Didier Blaise, Régis Peffault de Latour, Claude-Eric Bulabois, Eric Deconinck, Jakob Passweg, Edouard Forcade, Hélène Labussière-Wallet, Xavier Leleu, Anne-Lise Menard, Ali Bazarbachi, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Journal: Blood
Blood (2022) 140 (Supplement 1): 4876–4877.
https://doi.org/10.1182/blood-2022-165606
Published: 2022
Journal Articles

Allogeneic, CD34 + , Umbilical Cordblood-Derived NK Cell Adoptive Immunotherapy for the Treatment of Acute Myeloid Leukemia Patients with Measurable Residual Disease

Michael Heuser, Astrid Tschan-Plessl, Felicitas Thol, Adrian Schwarzer, Arnold Kloos, Nadine Kattre, Jakob Passweg, Kai Pinkernell, Arnold Ganser
Journal: Blood
Blood (2021) 138 (Supplement 1): 1745.
https://doi.org/10.1182/blood-2021-150138
Published: 2021
Journal Articles

Two-Year Landmark Survival Analysis after Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia: An Analysis from the ALWP of the EBMT

Vivek Patel, Myriam Labopin, Thomas Schroeder, Igor Wolfgang Blau, Lars Klingen Gjaerde, Mahmoud Aljurf, Gérard Socié, Urpu Salmenniemi, Wolfgang A Bethge, Jakob Passweg, Marie Balsat, Emma Nicholson, Johanna Tischer, Sebastian Giebel, Zinaida Peric, Eolia Brissot, Bhagirathbhai Dholaria, Bipin B. Savani, Arnon Nagler, Mohamad Mohty
Journal: Blood
Blood (2021) 138 (Supplement 1): 1822.
https://doi.org/10.1182/blood-2021-149821
Published: 2021
Journal Articles

An ounce of which prevention is worth a…?

Joerg Halter, Jakob Passweg
Journal: Blood
Blood (2021) 137 (14): 1852–1853.
https://doi.org/10.1182/blood.2021010688
Published: 2021
Journal Articles

Upfront Alternative Donor Transplant Versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack Fully HLA Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies. on Behalf of the Severe Aplastic Anemia Working Party of European Group for Blood and Marrow Transplantation (SAAWP of EBMT)

Hind Alotaibi, MBBS, Mahmoud Aljurf, Regis Peffault De Latour, MD PhD, Shahid Iqbal, Andrea Bacigalupo, Judith Marsh, Hubert Schrezenmeier, Eliane Gluckman, Mansour Alfayez, Britta Hoechsmann, Constantijn Halkes, Josu de la Fuente, Nawal AlShehry, Simone Cesaro, Jakob Passweg, Carlo Dufour, Antonio Risitano, John F. DiPersio, MD PhD, Ibraheem Motabi
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-140846
Published: 2020
Journal Articles

Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in Europe between 1995-2018: An EBMT Retrospective Analysis

Donal P. McLornan, MRCP, PhD FRCPath, Dirk-Jan Eikema, Nicolaus Kröger, MD, Linda Koster, Tomasz Czerw, MD PhD, Dietrich W. Beelen, MD, Emanuele Angelucci, Marie Robin, MD PhD, Martin Bornhaeuser, MD, Jakob Passweg, Grant McQuaker, MD, Antonin Vitek, Jürgen Finke, Sr., MD PhD, Igor W Blau, MD PhD, Riitta Niittyvuopio, Uwe Platzbecker, Jan J. Cornelissen, MD PhD, Patrice Chevallier, MD PhD, Micha Srour, Dragana Stamatovic, MDPhD, Joaquín Martínez-Lopez, Liesbeth C. de Wreede, PhD, Patrick J Hayden, MD, Juan Carlos Hernandez Boluda, Ibrahim Yakoub-Agha
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-134173
Published: 2020